NCT03183609View on ClinicalTrials.gov

Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 10, 2017

Primary Completion Date

March 30, 2024

Study Completion Date

March 30, 2024

Conditions
SchizophreniaGluten SensitivitySchizo Affective Disorder
Interventions
OTHER

Gluten Flour in Protein Shake

15 Grams Gluten Flour BID

OTHER

Rice Flour in Protein Shake

15 Grams Rice Flour BID

Trial Locations (1)

21228

Maryland Psychiatric Research Center (MPRC) Outpatient Research Program (ORP); the MPRC Treatment Research Program (TRP), Catonsville

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT03183609 - Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG) | Biotech Hunter | Biotech Hunter